Contract Research
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
300
NCT05941507
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Phase: Phase 1/2
Role: Collaborator
Start: Oct 5, 2023
Completion: May 31, 2027
Loading map...